Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2018, Article ID 7235639, 10 pages
https://doi.org/10.1155/2018/7235639
Research Article

Icaritin Provokes Serum Thrombopoietin and Downregulates Thrombopoietin/MPL of the Bone Marrow in a Mouse Model of Immune Thrombocytopenia

1National Key Research Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing 100191, China
2Department of Molecular and Cellular Pharmacology, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China

Correspondence should be addressed to Xiaoping Pu; nc.ude.umjb@321pxp

Received 6 April 2018; Revised 28 June 2018; Accepted 26 July 2018; Published 27 August 2018

Academic Editor: Raffaele Capasso

Copyright © 2018 Ke Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Nagalla and R. Sarode, “Recent advances in understanding and management of acquired thrombocytopenia,” F1000Research, vol. 7, p. 68, 2018. View at Publisher · View at Google Scholar · View at Scopus
  2. D. B. Cines, A. Cuker, and J. W. Semple, “Pathogenesis of immune thrombocytopenia,” Presse Médicale, vol. 43, no. 4, pp. e49–e59, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. M. P. Lambert and T. B. Gernsheimer, “Clinical updates in adult immune thrombocytopenia,” Blood, vol. 129, no. 21, pp. 2829–2835, 2017. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Pruemer, “Epidemiology, pathophysiology, and initial management of chronic immune thrombocytopenic purpura,” American Journal of Health-System Pharmacy, vol. 66, 2 Supplement 2, pp. S4–S10, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. B. Wormann, “Clinical indications for thrombopoietin and thrombopoietin-receptor agonists,” Transfusion Medicine and Hemotherapy, vol. 40, no. 5, pp. 319–325, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. J. L. Abkowitz and J. Chen, “Studies of c-Mpl function distinguish the replication of hematopoietic stem cells from the expansion of differentiating clones,” Blood, vol. 109, no. 12, pp. 5186–5190, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. R. S. Makar, O. S. Zhukov, M. A. Sahud, and D. J. Kuter, “Thrombopoietin levels in patients with disorders of platelet production: diagnostic potential and utility in predicting response to TPO receptor agonists,” American Journal of Hematology, vol. 88, no. 12, pp. 1041–1044, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. A. E. Geddis, H. M. Linden, and K. Kaushansky, “Thrombopoietin: a pan-hematopoietic cytokine,” Cytokine & Growth Factor Reviews, vol. 13, no. 1, pp. 61–73, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. J. G. Drachman, J. D. Griffin, and K. Kaushansky, “The c-Mpl ligand (thrombopoietin) stimulates tyrosine phosphorylation of Jak2, Shc, and c-Mpl,” The Journal of Biological Chemistry, vol. 270, no. 10, pp. 4979–4982, 1995. View at Publisher · View at Google Scholar · View at Scopus
  10. A. E. Geddis, N. E. Fox, and K. Kaushansky, “Phosphatidylinositol 3-kinase is necessary but not sufficient for thrombopoietin-induced proliferation in engineered Mpl-bearing cell lines as well as in primary megakaryocytic progenitors,” The Journal of Biological Chemistry, vol. 276, no. 37, pp. 34473–34479, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Rojnuckarin, J. G. Drachman, and K. Kaushansky, “Thrombopoietin-induced activation of the mitogen-activated protein kinase (MAPK) pathway in normal megakaryocytes: role in endomitosis,” Blood, vol. 94, no. 4, pp. 1273–1282, 1999. View at Google Scholar
  12. H. K. Kang, Y. H. Choi, H. Kwon et al., “Estrogenic/antiestrogenic activities of a Epimedium koreanum extract and its major components: in vitro and in vivo studies,” Food and Chemical Toxicology, vol. 50, no. 8, pp. 2751–2759, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. M. N. Islam, U. Kim, D. H. Kim, M. S. Dong, and H. H. Yoo, “High-performance liquid chromatography-based multivariate analysis to predict the estrogenic activity of an Epimedium koreanum extract,” Bioscience, Biotechnology, and Biochemistry, vol. 76, no. 5, pp. 923–927, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. J. S. Tong, Q. H. Zhang, X. Huang et al., “Icaritin causes sustained ERK1/2 activation and induces apoptosis in human endometrial cancer cells,” PLoS One, vol. 6, no. 3, article e16781, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Sun, J. Yang, L. Pan et al., “Improvement of icaritin on hematopoietic function in cyclophosphamide-induced myelosuppression mice,” Immunopharmacology and Immunotoxicology, vol. 40, no. 1, pp. 25–34, 2018. View at Publisher · View at Google Scholar · View at Scopus
  16. X. Lai, Y. Ye, C. Sun et al., “Icaritin exhibits anti-inflammatory effects in the mouse peritoneal macrophages and peritonitis model,” International Immunopharmacology, vol. 16, no. 1, pp. 41–49, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. F. Alves-Rosa, C. Stanganelli, J. Cabrera, N. van Rooijen, M. S. Palermo, and M. A. Isturiz, “Treatment with liposome-encapsulated clodronate as a new strategic approach in the management of immune thrombocytopenic purpura in a mouse model,” Blood, vol. 96, no. 8, pp. 2834–2840, 2000. View at Google Scholar
  18. X. Lin, L. Yin, R. Gao et al., “The effects of panaxadiol saponins on megakaryocytic maturation and immune function in a mouse model of immune thrombocytopenia,” Experimental Hematology, vol. 43, no. 5, pp. 364–373, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Sungaran, B. Markovic, and B. H. Chong, “Localization and regulation of thrombopoietin mRNa expression in human kidney, liver, bone marrow, and spleen using in situ hybridization,” Blood, vol. 89, no. 1, pp. 101–107, 1997. View at Google Scholar
  20. A. Gonzalez-Villalva, G. Pinon-Zarate, C. Falcon-Rodriguez et al., “Activation of Janus kinase/signal transducers and activators of transcription pathway involved in megakaryocyte proliferation induced by vanadium resembles some aspects of essential thrombocythemia,” Toxicology and Industrial Health, vol. 32, no. 5, pp. 908–918, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. J. N. Thon, A. Montalvo, S. Patel-Hett et al., “Cytoskeletal mechanics of proplatelet maturation and platelet release,” The Journal of Cell Biology, vol. 191, no. 4, pp. 861–874, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. T. Tang, P. He, Y. Z. Li et al., “Diagnostic value of platelet indices and bone marrow megakaryocytic parameters in immune thrombocytopenic purpura,” Blood Coagulation & Fibrinolysis, vol. 28, no. 1, pp. 83–90, 2017. View at Publisher · View at Google Scholar · View at Scopus
  23. J. W. Semple, “Animal models of immune thrombocytopenia (ITP),” Annals of Hematology, vol. 89, Supplement 1, pp. 37–44, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. R. Aslam, R. Kapur, G. B. Segel et al., “The spleen dictates platelet destruction, anti-platelet antibody production, and lymphocyte distribution patterns in a murine model of immune thrombocytopenia,” Experimental Hematology, vol. 44, no. 10, pp. 924–930.e1, 2016. View at Publisher · View at Google Scholar · View at Scopus
  25. K. R. Machlus, S. K. Wu, P. Vijey et al., “Selinexor-induced thrombocytopenia results from inhibition of thrombopoietin signaling in early megakaryopoiesis,” Blood, vol. 130, no. 9, pp. 1132–1143, 2017. View at Publisher · View at Google Scholar · View at Scopus
  26. F. Rodeghiero, R. Stasi, T. Gernsheimer et al., “Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group,” Blood, vol. 113, no. 11, pp. 2386–2393, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. F. Vianello, S. Vettore, F. Tezza et al., “Serum thrombopoietin and cMpl expression in thrombocytopenia of different etiologies,” Hematology Reports, vol. 6, no. 1, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. R. Borota, J. Borota, A. Belic, E. Gebauer, and N. Stefanovic, “Clinical use of thrombopoietin (c-Mpl ligand),” Medicinski Pregled, vol. 51, no. 11-12, pp. 501–508, 1998. View at Google Scholar
  29. A. Mohamed, A. Ibrahim, M. El-Masry et al., “Ex vivo expansion of stem cells: defining optimum conditions using various cytokines,” Laboratory Hematology, vol. 12, no. 2, pp. 86–93, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Nakeff and K. J. Roozendaal, “Thrombopoietin activity in mice following immune-induced thrombocytopenia,” Acta Haematologica, vol. 54, no. 6, pp. 340–344, 1975. View at Publisher · View at Google Scholar
  31. I. Vigon, F. Dreyfus, J. Melle et al., “Expression of the c-mpl proto-oncogene in human hematologic malignancies,” Blood, vol. 82, no. 3, pp. 877–883, 1993. View at Google Scholar